Asia Pacific Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Application (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Endocrine, Immunology, Nutritional & Metabolic Disease, Cardiology, Mental/Behavioral Disorder, Pediatrics-specific Testing, and Others), By Technology, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Laboratory Developed Tests Market would witness market growth of 7.4% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Laboratory Developed Tests Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,669.7 million by 2031. The Japan market is registering a CAGR of 7.1% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 7.8% during (2024 - 2031).

The emergence of personalized and precision medicine approaches has fueled demand for LDTs that enable molecular profiling, genetic testing, and targeted therapy selection. Healthcare providers seek to individualize treatment strategies based on patient’s genetic makeup, biomarker profiles, and disease characteristics, driving the adoption of LDTs in oncology, pharmacogenomics, and other therapeutic areas.

The market is characterized by several notable trends, reflecting technological advancements, changes in healthcare delivery models, and evolving regulatory landscapes. These trends shape LDT development, adoption, and utilization, influencing market dynamics and strategic priorities for laboratories and healthcare stakeholders. For example, the LDTs market has witnessed rapid advancements in molecular diagnostics, fueled by innovations in genomics, proteomics, and other omics technologies. Laboratories are developing increasingly sophisticated assays and testing platforms capable of detecting and analyzing molecular markers, genetic variants, and biological pathways associated with health and disease.

As chronic diseases become more common in India, diagnostic testing becomes more important to aid in the early detection, assessment, and tracking of these conditions. Laboratory-developed tests are crucial in diagnosing chronic diseases, assessing disease severity, monitoring treatment response, and guiding clinical management decisions. According to Down to Earth, among Indians over 45, cardiovascular illnesses (CVD) are the most common. The prevalence of diagnosed CVD in the age group 45-49 is 19 percent and is 37 percent for the population above 75. Chronic hypertension follows a similar trajectory. Approximately 18% of people between 45 and 49 years old have hypertension, this number rises to 28% in those between 60 and 64 and 35% in those between 70 and 74 years old. As a result, the demand for LDTs tailored to the detection and characterization of chronic diseases is expected to increase.

Free Valuable Insights: The Global Laboratory Developed Tests Market is Predict to reach USD 20.3 Billion by 2031, at a CAGR of 6.9%

Based on Application, the market is segmented into Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Endocrine, Immunology, Nutritional & Metabolic Disease, Cardiology, Mental/Behavioral Disorder, Pediatrics-specific Testing, and Others. Based on Technology, the market is segmented into Molecular Diagnostics, Immunoassays, Hematology & Coagulation, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Neogenomics, Inc.
• Guardant Health, Inc.
• Qiagen N.V
• Quest Diagnostics Incorporated
• Abbott Laboratories
• Siemens Healthineers AG (Siemens AG)
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• F.Hoffmann-La Roche Ltd.
• Eurofins Scientific SE

Asia Pacific Laboratory Developed Tests Market Report Segmentation

By Application

• Oncology
• Genetic Disorders/Inherited Disease
• Infectious & Parasitic Diseases
• Endocrine
• Immunology
• Nutritional & Metabolic Disease
• Cardiology
• Mental/Behavioral Disorder
• Pediatrics-specific Testing
• Others

By Technology

• Molecular Diagnostics
• Immunoassays
• Hematology & Coagulation
• Microbiology
• Clinical Chemistry
• Histology/Cytology
• Flow Cytometry
• Mass Spectroscopy
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Laboratory Developed Tests Market, by Application
1.4.2 Asia Pacific Laboratory Developed Tests Market, by Technology
1.4.3 Asia Pacific Laboratory Developed Tests Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Laboratory Developed Tests Market.

Chapter 5. Asia Pacific Laboratory Developed Tests Market by Application
5.1 Asia Pacific Oncology Market by Country
5.2 Asia Pacific Genetic Disorders/Inherited Disease Market by Country
5.3 Asia Pacific Infectious & Parasitic Diseases Market by Country
5.4 Asia Pacific Endocrine Market by Country
5.5 Asia Pacific Immunology Market by Country
5.6 Asia Pacific Nutritional & Metabolic Disease Market by Country
5.7 Asia Pacific Cardiology Market by Country
5.8 Asia Pacific Mental/Behavioral Disorder Market by Country
5.9 Asia Pacific Pediatrics-specific Testing Market by Country
5.1 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Laboratory Developed Tests Market by Technology
6.1 Asia Pacific Molecular Diagnostics Market by Country
6.2 Asia Pacific Immunoassays Market by Country
6.3 Asia Pacific Hematology & Coagulation Market by Country
6.4 Asia Pacific Microbiology Market by Country
6.5 Asia Pacific Clinical Chemistry Market by Country
6.6 Asia Pacific Histology/Cytology Market by Country
6.7 Asia Pacific Flow Cytometry Market by Country
6.8 Asia Pacific Mass Spectroscopy Market by Country
6.9 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Laboratory Developed Tests Market by Country
7.1 China Laboratory Developed Tests Market
7.1.1 China Laboratory Developed Tests Market by Application
7.1.2 China Laboratory Developed Tests Market by Technology
7.2 Japan Laboratory Developed Tests Market
7.2.1 Japan Laboratory Developed Tests Market by Application
7.2.2 Japan Laboratory Developed Tests Market by Technology
7.3 India Laboratory Developed Tests Market
7.3.1 India Laboratory Developed Tests Market by Application
7.3.2 India Laboratory Developed Tests Market by Technology
7.4 South Korea Laboratory Developed Tests Market
7.4.1 South Korea Laboratory Developed Tests Market by Application
7.4.2 South Korea Laboratory Developed Tests Market by Technology
7.5 Singapore Laboratory Developed Tests Market
7.5.1 Singapore Laboratory Developed Tests Market by Application
7.5.2 Singapore Laboratory Developed Tests Market by Technology
7.6 Malaysia Laboratory Developed Tests Market
7.6.1 Malaysia Laboratory Developed Tests Market by Application
7.6.2 Malaysia Laboratory Developed Tests Market by Technology
7.7 Rest of Asia Pacific Laboratory Developed Tests Market
7.7.1 Rest of Asia Pacific Laboratory Developed Tests Market by Application
7.7.2 Rest of Asia Pacific Laboratory Developed Tests Market by Technology

Chapter 8. Company Profiles
8.1 Neogenomics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Guardant Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Quest Diagnostics Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.4.5 SWOT Analysis
8.5 Abbott Laboratories
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segment and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bio-Rad laboratories, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Eurofins Scientific SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 SWOT Analysis

TABLE 1 Asia Pacific Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 3 Asia Pacific Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 4 Asia Pacific Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 5 Asia Pacific Oncology Market by Country, 2020 - 2023, USD Million
TABLE 6 Asia Pacific Oncology Market by Country, 2024 - 2031, USD Million
TABLE 7 Asia Pacific Genetic Disorders/Inherited Disease Market by Country, 2020 - 2023, USD Million
TABLE 8 Asia Pacific Genetic Disorders/Inherited Disease Market by Country, 2024 - 2031, USD Million
TABLE 9 Asia Pacific Infectious & Parasitic Diseases Market by Country, 2020 - 2023, USD Million
TABLE 10 Asia Pacific Infectious & Parasitic Diseases Market by Country, 2024 - 2031, USD Million
TABLE 11 Asia Pacific Endocrine Market by Country, 2020 - 2023, USD Million
TABLE 12 Asia Pacific Endocrine Market by Country, 2024 - 2031, USD Million
TABLE 13 Asia Pacific Immunology Market by Country, 2020 - 2023, USD Million
TABLE 14 Asia Pacific Immunology Market by Country, 2024 - 2031, USD Million
TABLE 15 Asia Pacific Nutritional & Metabolic Disease Market by Country, 2020 - 2023, USD Million
TABLE 16 Asia Pacific Nutritional & Metabolic Disease Market by Country, 2024 - 2031, USD Million
TABLE 17 Asia Pacific Cardiology Market by Country, 2020 - 2023, USD Million
TABLE 18 Asia Pacific Cardiology Market by Country, 2024 - 2031, USD Million
TABLE 19 Asia Pacific Mental/Behavioral Disorder Market by Country, 2020 - 2023, USD Million
TABLE 20 Asia Pacific Mental/Behavioral Disorder Market by Country, 2024 - 2031, USD Million
TABLE 21 Asia Pacific Pediatrics-specific Testing Market by Country, 2020 - 2023, USD Million
TABLE 22 Asia Pacific Pediatrics-specific Testing Market by Country, 2024 - 2031, USD Million
TABLE 23 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 24 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 25 Asia Pacific Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 26 Asia Pacific Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 27 Asia Pacific Molecular Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 28 Asia Pacific Molecular Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 29 Asia Pacific Immunoassays Market by Country, 2020 - 2023, USD Million
TABLE 30 Asia Pacific Immunoassays Market by Country, 2024 - 2031, USD Million
TABLE 31 Asia Pacific Hematology & Coagulation Market by Country, 2020 - 2023, USD Million
TABLE 32 Asia Pacific Hematology & Coagulation Market by Country, 2024 - 2031, USD Million
TABLE 33 Asia Pacific Microbiology Market by Country, 2020 - 2023, USD Million
TABLE 34 Asia Pacific Microbiology Market by Country, 2024 - 2031, USD Million
TABLE 35 Asia Pacific Clinical Chemistry Market by Country, 2020 - 2023, USD Million
TABLE 36 Asia Pacific Clinical Chemistry Market by Country, 2024 - 2031, USD Million
TABLE 37 Asia Pacific Histology/Cytology Market by Country, 2020 - 2023, USD Million
TABLE 38 Asia Pacific Histology/Cytology Market by Country, 2024 - 2031, USD Million
TABLE 39 Asia Pacific Flow Cytometry Market by Country, 2020 - 2023, USD Million
TABLE 40 Asia Pacific Flow Cytometry Market by Country, 2024 - 2031, USD Million
TABLE 41 Asia Pacific Mass Spectroscopy Market by Country, 2020 - 2023, USD Million
TABLE 42 Asia Pacific Mass Spectroscopy Market by Country, 2024 - 2031, USD Million
TABLE 43 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 44 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 45 Asia Pacific Laboratory Developed Tests Market by Country, 2020 - 2023, USD Million
TABLE 46 Asia Pacific Laboratory Developed Tests Market by Country, 2024 - 2031, USD Million
TABLE 47 China Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 48 China Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 49 China Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 50 China Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 51 China Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 52 China Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 53 Japan Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 54 Japan Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 55 Japan Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 56 Japan Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 57 Japan Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 58 Japan Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 59 India Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 60 India Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 61 India Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 62 India Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 63 India Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 64 India Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 65 South Korea Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 66 South Korea Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 67 South Korea Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 68 South Korea Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 69 South Korea Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 70 South Korea Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 71 Singapore Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 72 Singapore Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 73 Singapore Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 74 Singapore Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 75 Singapore Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 76 Singapore Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 77 Malaysia Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 78 Malaysia Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 79 Malaysia Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 80 Malaysia Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 81 Malaysia Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 82 Malaysia Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 83 Rest of Asia Pacific Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 84 Rest of Asia Pacific Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 85 Rest of Asia Pacific Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 86 Rest of Asia Pacific Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 87 Rest of Asia Pacific Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 88 Rest of Asia Pacific Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 89 Key Information – neogenomics, inc.
TABLE 90 Key Information – GUARDANT HEALTH, INC.
TABLE 91 Key Information – Qiagen N.V.
TABLE 92 Key information – Quest Diagnostics Incorporated
TABLE 93 Key Information – Abbott Laboratories
TABLE 94 Key Information – Siemens Healthineers AG
TABLE 95 key information – Illumina, Inc.
TABLE 96 Key Information – Bio-Rad Laboratories, Inc.
TABLE 97 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 98 Key Information – Eurofins Scientific SE

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Laboratory Developed Tests Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Laboratory Developed Tests Market
FIG 4 Porter’s Five Forces Analysis – Laboratory Developed Tests Market
FIG 5 Asia Pacific Laboratory Developed Tests Market share by Application, 2023
FIG 6 Asia Pacific Laboratory Developed Tests Market share by Application, 2031
FIG 7 Asia Pacific Laboratory Developed Tests Market by Application, 2020 - 2031, USD Million
FIG 8 Asia Pacific Laboratory Developed Tests Market share by Technology, 2023
FIG 9 Asia Pacific Laboratory Developed Tests Market share by Technology, 2031
FIG 10 Asia Pacific Laboratory Developed Tests Market by Technology, 2020 - 2031, USD Million
FIG 11 Asia Pacific Laboratory Developed Tests Market share by Country, 2023
FIG 12 Asia Pacific Laboratory Developed Tests Market share by Country, 2031
FIG 13 Asia Pacific Laboratory Developed Tests Market by Country, 2020 - 2031, USD Million
FIG 14 Swot Analysis: Neogenomics, Inc.
FIG 15 Swot Analysis: Guardant Health, Inc.
FIG 16 Recent strategies and developments: Qiagen N.V.
FIG 17 Swot Analysis: Qiagen N.V.
FIG 18 SWOT Analysis: Quest Diagnostics Incorporated
FIG 19 SWOT Analysis: Abbott Laboratories
FIG 20 SWOT Analysis: Siemens Healthineers AG
FIG 21 Swot Analysis: Illumina, Inc.
FIG 22 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 23 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 24 SWOT Analysis: Eurofins Scientific SEs